Genzyme | search
Click here to view Genzyme news from 60+ newspapers.
Bookmark or Share- Genzyme - WikipediaGenzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world's third-largest biotechnology company, employing more than 11,000 people ...
- Eleven years after buying Genzyme, Sanofi officially ditches ... - STATEleven years after Sanofi bought Genzyme for about $20.1 billion, the parent company said Thursday it will no longer call its specialty care unit Sanofi Genzyme ― just Sanofi, as part of a ...
- Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USAEmpowering Communities Through Science and Service. Sanofi employees are making a positive impact through volunteerism, charitable donations, and community partnerships.
- Special Report: Inside the battle for Genzyme's futureUnder its articles of organization Genzyme could force Biosurgery shareholders to sell their shares back at 130 percent of fair market value. Genzyme acquired Biosurgery shares for $1.77 each.
- Sanofi buys Genzyme for $20.1bn - Financial TimesSanofi-Aventis has ended a nine-month pursuit of US biotech company Genzyme with a $20.1bn deal worth $74 a share, Bloomberg says. The French drugmaker will now be able to add rare disease ...
More
